CD274 (PD-L1) is not only associated with decreased cytotoxic T lymphocytes and increased Tregs in glioma lesions, but also has an intrinsic oncogenic effect through interaction with Ras (10.3389/fphar.2018.01503). Here, CD274 is linked to glioma.